Cite
APA Citation
Müller, V., Ruhnke, M., Hoffmann, O., Grafe, A., Tomé, O., Fett, W., Bruch, H., Sommer-Joos, A., & Schneeweiss, A. (2021). first-line bevacizumab-containing therapy for HER2-negative locally advanced/metastatic breast cancer: Real-world experience from >2000 patients treated in the multicentre AVANTI study. Breast, 60, 70–77. http://access.bl.uk/ark:/81055/vdc_100148050714.0x00003f